Vaginal applicator
Latest Ortho Pharmaceutical Corporation Patents:
- Liquid phase peptide synthesis of KL-4 pulmonary surfactant
- Purification of antigen-specific T cells
- Liquid phase peptide syntheses of KL-4 pulmonary surfactant
- Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
- DNA encoding a human histamine receptor of the H3 subtype
Description
FIG. 1 is a top plan view of a vaginal applicator showing my new design;
FIG. 2 is a cross-section taken on line 2--2 of FIG. 3;
FIG. 3 is an end elevation of the application; and
FIG. 4 is a cross-section taken on line 4--4 of FIG. 2.
Referenced Cited
U.S. Patent Documents
D103534 | March 1937 | Lermer |
D197751 | March 1964 | Rigney et al. |
D236035 | July 1975 | Ciencewicki |
D250049 | October 24, 1978 | Hite, Jr. |
D250663 | December 26, 1978 | Koch et al. |
D260814 | September 15, 1981 | Goldhardt |
2742902 | April 1956 | Scheibler |
3757781 | September 1973 | Smart |
4173227 | November 6, 1979 | Cassou et al. |
4261361 | April 14, 1981 | Cassou |
Patent History
Patent number: D279504
Type: Grant
Filed: May 15, 1981
Date of Patent: Jul 2, 1985
Assignee: Ortho Pharmaceutical Corporation (Raritan, NJ)
Inventor: Dirk Tump (Lebanon, NJ)
Primary Examiner: Bernard Ansher
Attorney: Benjamin F. Lambert
Application Number: 6/305,416
Type: Grant
Filed: May 15, 1981
Date of Patent: Jul 2, 1985
Assignee: Ortho Pharmaceutical Corporation (Raritan, NJ)
Inventor: Dirk Tump (Lebanon, NJ)
Primary Examiner: Bernard Ansher
Attorney: Benjamin F. Lambert
Application Number: 6/305,416
Classifications
Current U.S. Class:
D24/63;
D24/59;
D24/99;
D24/17